"Updated survival outcomes and analysis of long-term survivors from the MORE study on safety and efficacy of radioembolization in patients with unresectable colorectal cancer liver metastases." by Andrew Kennedy

Article

Updated survival outcomes and analysis of long-term survivors from the MORE study on safety and efficacy of radioembolization in patients with unresectable colorectal cancer liver metastases.

Journal of gastrointestinal oncology (2017)

Andrew Kennedy, Sarah Cannon Research Institute
Michael Cohn, Radiology Associates of Hollywood, Pembroke Pines, FL, USA.
Douglas M. Coldwell, University of Louisville
Alain Drooz, Fairfax Radiological Consultants, Fairfax, VA, USA.
Eduardo Ehrenwald, Abbott Northwestern Hospital
Adeel Kaiser, University of Maryland Medical Center
Charles W. Nutting, Radiology Imaging Associates, Englewood, CO, USA.
Steven C. Rose, University of California, San Diego
Eric A. Wang, Charlotte Radiology, Charlotte, NC, USA.
Michael A. Savin, Oakland University

Link

Disciplines

Publication Date

March 22, 2017

DOI

10.21037/JGO.2017.03.10

Citation Information

Andrew Kennedy, Michael Cohn, Douglas M. Coldwell, Alain Drooz, et al.. "Updated survival outcomes and analysis of long-term survivors from the MORE study on safety and efficacy of radioembolization in patients with unresectable colorectal cancer liver metastases." Journal of gastrointestinal oncology Vol. 8 Iss. 4 (2017) p. 614 - 624
Available at: http://works.bepress.com/adeel-kaiser/4/